Lion Biotechnologies (LBIO) Enters Licensing Agreement for Glioblastoma, Pancreatic Cancer Studies
Go back to Lion Biotechnologies (LBIO) Enters Licensing Agreement for Glioblastoma, Pancreatic Cancer Studies| Lion Biotechnologies, Inc. (NASDAQ: LBIO) | Delayed: 6.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $9.58 | |||
| Open | $83.63 | 52 Week Low | $4.24 | |||
| Day High | $6.95 | P/E | N/A | |||
| Day Low | $6.95 | EPS | $0.00 | |||
| Volume | 993,933 | |||||
